Cargando…
YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. A growing body of evidence suggests that mitochondrial dysfunction and inflammation play a crucial role as a pathogenetic mechanism in PD. The glycoprotein YKL-40 (CHI3L1) is a potential biomarker involved in inf...
Autores principales: | Gevezova, Maria, Kazakova, Maria, Trenova, Anastasia, Sarafian, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671493/ https://www.ncbi.nlm.nih.gov/pubmed/38003487 http://dx.doi.org/10.3390/ijms242216297 |
Ejemplares similares
-
Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer
por: De Robertis, Mariangela, et al.
Publicado: (2022) -
Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
por: Minchev, Danail, et al.
Publicado: (2022) -
Effect on Cellular Vitality In Vitro of Novel APRF-Chlorhexidine Treated Membranes
por: Gavrailov, Tasho, et al.
Publicado: (2022) -
Redox regulation of the immune response
por: Morris, Gerwyn, et al.
Publicado: (2022) -
Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)